期刊文献+

人脂联素重组克隆载体构建

Reconstruction of Eukaryotic Expression Vector Containing Human Adiponectin Gene
原文传递
导出
摘要 目的:构建含有人脂联素(adiponectin,ad)基因的重组克隆载体pEGFP-N1-AD,为进一步研究AD与脂质代谢及代谢综合征关系奠定基础。方法:根据Gene-Bank中已经公布的AD设计引物,从含有目的基因的质粒克隆模板中,利用PCR方法钓取目的基因。将AD基因克隆到真核表达载体pEGFP-N1中。酶切、PCR、及测序鉴定。结果:PCR、酶切及测序鉴定证实目的基因正确克隆至真核表达载体pEGFP-N1中,测序结果与Gene-Bank报道一致。结论:成功构建了AD重组克隆真核表达载体。 Objective: To construct the vector (pEGFP-N1-AD) containing human adiponectin (AD)gene so as to investigate the effects of adiponectin in the lipid metabolism and the syndrome of metabolism. Methods: AD gene was amplified from the plasma by polymerase chain reaction (PCR) technique whose primer was designed according to the announced sequences ofAD gene in gene bank, then cut by the endonucleases and directionally cloned into the pEGFP-N1 vector and analyzed by endonuclease cutting,PCR and gene sequencing analysis. Results: Through PCR, endonuclease cutting and gene sequencing,the target gene was verified to be correctly cloned to vector pEGFP-N1. Conclusion: Recombinant eukaryotic expression vector containing human adiponectin protein was successfully constructed.
出处 《现代生物医学进展》 CAS 2011年第20期3805-3808,共4页 Progress in Modern Biomedicine
基金 院级基金资助(H-425)
关键词 脂联素 慢病毒载体 构建 表达 Adiponectin Vector Construction
  • 相关文献

参考文献26

  • 1Olanow CW,Obeso JA. Preventing levodopa-induced dyskinesias. Ann Neurol, 2000,47Suppl 1:S167-S178.
  • 2Thomas J, Wang J, Takuba H, et al. A 6-OHDA induced selective Parkinsonian rat model: further biochemical and behavioural characterization. Exp Neurol, 1994,126: 159-167.
  • 3Lee CS,Cenei MA ,Schulzer M,et al. Embryonic ventral mesencephalic grafts improve levodopa - induced dyskinesia in a rat model of Parkinson's disease. Brain, 2000, 123:1365-1379.
  • 4Guldner FH, Ingham CA. Increase in postsynaptic density material in optic target neuron of the rat suprachiasmatic nucleus after bilateral enucleation. Neurosci Lett,1980, 17:27-31.
  • 5Ingham CA, Hood SH,Taggart P, et al. Plasticity of synapse in the rat neostriatum after unilateral lesion of the nigrostriatal dopamine pathway. J Neurosci,1998,18: 4732-4743.
  • 6Anglade P,Mouati-Prigent A, Agid Y,et al. Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease. Neurodegeneration, 1996,5:121-128.
  • 7Yamauchi T. Molecular constituents and phosphorylation-dependent regulation of the post-synaptic density. Mass Spectrom Rev, 2002,21:266-286.
  • 8Soderling TR,Derkach VA. Postsynaptic protein phosphorylation and LTP. Trends Neurosci, 2000,23: 75-80.
  • 9Okabe S. NMDA receptors and their interacting proteins in the post synaptic density. Kaibogaku Zasshi, 2001,76: 185-191.
  • 10Jones DG,Harris RJ. An analysis of contemporary morphological concepts of synaptic remodelling in the CNS: perforated synapses revisited. Rev Neurosci, 1995, 6 : 177-219.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部